GoodRx Holdings Inc [GDRX] stock is trading at $7.79, up 20.40%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GDRX shares have gain 19.11% over the last week, with a monthly amount glided 26.46%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 29, February 2024, GoodRx Reports Fourth Quarter and Full Year 2023 Results. In a post published today on Yahoo Finance, GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024.
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on February 26, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $8. Previously, BofA Securities downgraded its rating to Underperform on January 02, 2024, and dropped its price target to $4.50. On August 10, 2023, upgrade upgraded it’s rating to Buy but maintained its price target of $9.50 on the stock. TD Cowen upgraded its rating to a Outperform and increased its price target to $12 on July 31, 2023. Citigroup initiated its recommendation with a Buy and recommended $7 as its price target on December 01, 2022. JP Morgan upgraded its rating to Neutral for this stock on November 04, 2022, and downed its price target to $8. In a note dated September 16, 2022, KeyBanc Capital Markets initiated an Sector Weight rating.
GoodRx Holdings Inc [GDRX] stock has fluctuated between $4.14 and $9.37 over the past year. Currently, Wall Street analysts expect the stock to reach $17.4 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $7.79 at the most recent close of the market. An investor can expect a potential return of 123.36% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
GoodRx Holdings Inc [NASDAQ:GDRX] reported sales of 737.73M for the trailing twelve months, which represents a drop of -3.93%. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.24 points at the first support level, and at 6.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.17, and for the 2nd resistance point, it is at 8.55.
GoodRx Holdings Inc [GDRX] reported earnings per share of $0.06 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.06/share, meaning a difference of $0 and a surprise factor of 0.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were $0.07 per share as compared to estimates of $0.06 per share, a difference of $0.01 representing a surprise of 16.70%.
Ratios To Look Out For
For context, GoodRx Holdings Inc’s Current Ratio is 8.23. Further, the Quick Ratio stands at 8.23, while the Cash Ratio is 5.49. Considering the valuation of this stock, the price to sales ratio is 4.29, the price to book ratio is 3.52 and price to earnings (TTM) ratio is 216.39.
Transactions by insiders
Recent insider trading involved Wagner Scott, that happened on Nov 30 when 21652.0 shares were purchased., Wagner Scott completed a deal on Nov 29 to buy 26348.0 shares. Meanwhile, Wagner Scott bought 4157.0 shares on Nov 28.
